Avidity Biosciences Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,734 | -11,216 | N/A | -22,050 | N/A |
| Depreciation Amortization | 419 | 456 | N/A | 1,590 | N/A |
| Other Working Capital | 19,357 | 671 | N/A | -11,150 | N/A |
| Other Operating Activity | 7,448 | 434 | 0 | 2,430 | 0 |
| Operating Cash Flow | $2,490 | $-9,655 | $N/A | $-29,180 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -235 | -49 | N/A | -800 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 240 | 0 |
| Investing Cash Flow | $-235 | $-49 | $N/A | $-560 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,451 | 4,982 | N/A | N/A | N/A |
| Debt Repayment | -2,800 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 65 | 162 | N/A | N/A | N/A |
| Other Financing Activity | 72,517 | 0 | 0 | 84,840 | 0 |
| Financing Cash Flow | $89,233 | $5,144 | $N/A | $84,840 | $N/A |
| Exchange Rate Effect | N/A | N/A | N/A | 10 | N/A |
| Beginning Cash Position | 3,090 | 7,650 | N/A | 54,110 | N/A |
| End Cash Position | 94,578 | 3,090 | N/A | 109,220 | N/A |
| Net Cash Flow | $91,488 | $-4,560 | $N/A | $55,110 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,490 | -9,655 | N/A | -29,180 | N/A |
| Capital Expenditure | -235 | -49 | N/A | N/A | N/A |
| Free Cash Flow | 2,255 | -9,704 | 0 | -29,180 | 0 |